Slawomir Szymanski
About Slawomir Szymanski
Slawomir Szymanski is the Director of Program Management at Marker Therapeutics, Inc. in Houston, Texas, with a background in organic chemistry and extensive experience in cancer research and pharmaceuticals.
Current Role at Marker Therapeutics
Slawomir Szymanski serves as the Director of Program Management at Marker Therapeutics, Inc. He has held this position since 2019. In this role, he is responsible for overseeing various aspects of program management within the organization, contributing to the development and execution of strategies that align with the company's objectives. Marker Therapeutics is based in Houston, Texas, and focuses on innovative therapies in the field of cancer treatment.
Previous Experience at Bellicum Pharmaceuticals
Prior to his current role, Slawomir Szymanski worked at Bellicum Pharmaceuticals, Inc. He held the position of Associate Director for a brief period in 2019, lasting two months. Additionally, he served as a Senior Scientist at Bellicum from 2016 to 2019, where he contributed to research and development efforts in the biopharmaceutical sector.
Research Background at MD Anderson Cancer Center
Slawomir Szymanski has an extensive research background at MD Anderson Cancer Center. He began his tenure there as a Post-doctoral fellow from 2001 to 2004, a role he held for three years. Following this, he worked as a Senior Research Assistant and Research Investigator from 2004 to 2007, also for three years. His work at MD Anderson contributed to advancements in cancer research and treatment methodologies.
Educational Qualifications in Organic Chemistry
Slawomir Szymanski earned his Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Warsaw. His studies spanned from 1992 to 2000, covering a period of eight years. This academic background provided him with a strong foundation in chemical research, which has been instrumental in his subsequent career in the biopharmaceutical industry.